Ben Braverman is an "operator first, investor second" venture capitalist who personally led Flexport's go-to-market from zero to $2B in sales before moving into investing, giving him unusually deep sales and operational experience compared to career investors. He focuses on "second-order AI" and infrastructure-heavy companies at seed stage, leveraging his background in global trade and supply chain to evaluate AI-driven companies that must integrate with real-world logistics rather than pure software.

• Deep appreciation for aggressive sales velocity and go-to-market strategy, likely stemming from his background as a sales executive at Flexport. He explicitly values rapid execution, having offered a guaranteed meeting and a dinner at Kokkari to any founder capable of growing revenue from zero to two million dollars in just three months.
• Investment focus on hard tech, defense, and reindustrialization, often referred to as rebuilding the arsenal of democracy. He frequently praises companies like Hadrian and Anduril that treat the factory itself as a product and are successfully creating entirely new categories rather than just finding market fit.
• Curiosity about biotechnology and human enhancement, specifically looking for scientific breakthroughs that improve daily quality of life. He has mused about the potential of myostatin inhibitors for muscle mass, nootropics for flow states, and the underlying mechanisms of GLP-1 weight loss drugs.
• Preference for founders who exhibit extreme conviction and an ability to tune out distractions. He highlighted a specific portfolio founder working on a difficult physics problem who uses a basic flip phone, viewing this choice as a non-coincidental signal of the intensity required to solve hard problems.
• A thesis that prioritizes operational expertise in venture capital, positioning Saga Ventures as a partner for pre-seed through Series A rounds. He contrasts his approach with mega-funds, suggesting that founders benefit more from partnering with seasoned operators who act as true allies rather than just passive sources of capital.